{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Reports of Loperamide ODs Reveal a New Cardiotoxic Opioid
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Description
Method of Participation in the Learning Process/Evaluation Method Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form. Getting the Most out of the Activity As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.Accreditation Statement:
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Learning Objectives
After completing this continuing education activity you will be able to:
Suspect loperamide overdose by its cardiotoxic symptoms and to treat it with a variety of therapies.
Disclosures
The author, faculty and staff have no financial relationships with any ineligible organizations regarding this educational activity.
Price:
$10.00
Credits:
- ACPE 1.0 CH
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. UAN# 0431-0000-22-024-H04-P
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Professions:
Pharmacist
Test Code: EMN0418PH
Published: April 2019
Expires: 9/13/2025
Sources:
Allied Health Collection
Required Passing Score: 8/10 (80%)
Categories:
Pharmacology
Specialties:
Cardiology,
Pharmocotherapy